Xcout Intel
Anaveon AG competitors & alternatives
The 12 closest competitors and alternatives to Anaveon AG among biotechnology companies — ranked by similarity to what Anaveon AG actually does, not by market-cap band.
Subscribe to see Anaveon AG’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Anaveon AG
Anaveon is a late-stage preclinical biotechnology company based in Basel, Switzerland, focused on developing engineered antibodies for immunotherapy.
Anaveon AG at a glance
Anaveon AG is a biotechnology company headquartered in Switzerland. It has raised at least $121M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Series B, raised $121M in December 2021. Xcout tracks 4 named people at Anaveon AG, including Thaminda Ramanayake (Chief Executive Officer).
Anaveon AG leadership
- Thaminda RamanayakeChief Executive Officer
- Jill JeneChief Business Officer
- Laetitia PouzolChief Scientific Officer
- Thomas P. MathersChairman
Anaveon AG funding rounds
At least $121M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $121M | 3 named | |
| Series A | Undisclosed | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Anaveon AG competitors
Ranked by semantic similarity — how close each company is to Anaveon AG by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Polyneuron Pharmaceuticals is a venture-backed biotech and life sciences company headquartered in Basel, Switzerland. Founded in 2014, the company is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases.
Similar biotechnology company
NBE-Therapeutics is a biotechnology company founded in 2012 and headquartered in Basel, Switzerland, focused on developing antibody-drug conjugates for oncology treatments.
Similar biotechnology company
Curon Biopharmaceutical is a clinical-stage biotechnology company developing antibody-based medicines, including bispecific antibodies, for cancer and other serious diseases. It serves patients and healthcare providers through the development of therapeutic biologics, with programs intended for oncology and immunology applications.
Similar biotechnology company
Aptevo Therapeutics Inc. is a public, clinical-stage biotechnology company headquartered in Seattle, Washington, focused on developing novel bispecific and trispecific immunotherapies for immuno-oncology.
Similar biotechnology company
VAXIMM AG is a biotech company headquartered in Basel, Switzerland, that focuses on developing a new class of cytotoxic immunotherapies and clinical-stage targeted treatments through its subsidiaries.
Biotech
Numab Therapeutics is a Swiss biotechnology company developing multispecific antibody-based medicines that modulate immune-cell interactions. Its programs target serious diseases including cancer and immune-mediated or inflammatory disorders, serving patients through development and potential partnerships with pharmaceutical companies.
Similar biotechnology company
Amphivena Therapeutics, Inc. is a privately held, clinical-stage biotechnology company based in South San Francisco, California. The company specializes in immuno-oncology, developing a platform of dual-function biologics and selective T cell engagers for the treatment of hematological conditions.
Biotech
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
Similar biotechnology company
GlycoEra AG is a biotechnology company focused on advancing glycan-mediated therapy through game-changing protein engineering. Headquartered in Wädenswil, Switzerland, the company also maintains an office in Newton, Massachusetts.
Biotech
Philogen is a Swiss-Italian biotechnology company that focuses on the research, development, and commercialization of targeted therapeutics for the treatment of cancer and other serious conditions. The company utilizes proprietary antibody-based technologies to develop biopharmaceuticals, immunotherapies, and radio-conjugates for oncology and imaging applications.
Similar biotechnology company
Kanyos Bio, Inc. is a biotechnology company located in Cambridge, Massachusetts, created as a subsidiary of Anokion SA to develop clinical candidates for immune tolerance.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Anaveon AG and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Anaveon AGand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →